Enhancing Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities (HBCUs) (UG3/UH3 Clinical Trial Not Allowed)
ID: 350542Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $300K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/350542

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-EB-23-006.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Enhancing Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities (HBCUs)." This initiative aims to enhance research capacity and educational infrastructure at HBCUs by supporting the development of biomedical engineering departments, interdisciplinary technology centers, and academic programs focused on addressing health disparities in underserved populations. The funding mechanism consists of a two-phase cooperative agreement, with Phase I (UG3) providing up to $300,000 annually for planning over three years, and Phase II (UH3) allowing up to $1 million per year for implementation over four years. Interested applicants must adhere to specific registration and submission requirements, with a closing date for applications set for September 30, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/rfa-files/RFA-EB-23-006.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-EB-23-006-Full-Announcement.html
    RFA-EB-23-006.html
    The Department of Health and Human Services announces a funding opportunity aimed at enhancing biomedical research and educational infrastructure at Historically Black Colleges and Universities (HBCUs) through the Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) program. This initiative, led by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), seeks to build research capacity and technological innovation to address health disparities affecting underserved populations. The funding mechanism consists of a two-phase cooperative agreement: Phase I (UG3) allows up to $300,000 annually for planning over three years, while Phase II (UH3) permits up to $1 million per year for implementation over four years. Key application components include a detailed Milestone Plan, descriptions of institutional support, and a commitment to sustainable development. Eligible applicants are primarily HBCUs, with emphasis on promoting diversity in the biomedical workforce. The application process includes specific requirements for registrations, submissions via Grants.gov, and adherence to NIH policies on data management and sharing. Overall, this funding opportunity aims to leverage HBCUs' contributions to biomedical advancement and career preparation while fostering diversity within the scientific community.
    Similar Opportunities
    Building Biomedical Engineering Education, Research, and Innovation at Historically Black Colleges and Universities (HBCU eBETA) (UG3/UH3 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Building Biomedical Engineering Education, Research, and Innovation at Historically Black Colleges and Universities (HBCU eBETA)," aimed at enhancing research capacity and technology innovation in biomedical engineering at HBCUs. This initiative seeks to bolster education and career development in biomedical engineering, with a phased funding approach allowing for up to $300,000 in direct costs for planning (UG3 Phase) and potentially up to $1,000,000 for full-scale program implementation (UH3 Phase). The program emphasizes the importance of diversity in the scientific workforce and aims to address health disparities through improved training and partnerships. Interested applicants must submit their proposals by September 30, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. More details can be found at the provided link: https://grants.nih.gov/grants/guide/rfa-files/RFA-EB-25-002.html.
    Team-Based Design in Biomedical Engineering Education (R25 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Team-Based Design in Biomedical Engineering Education (R25 Clinical Trial Not Allowed)" aimed at enhancing biomedical engineering education through innovative team-based design courses. This initiative seeks to support educational programs that prepare undergraduate students in biomedical engineering/bioengineering fields to meet national biomedical needs, with a focus on promoting health equity and universal design. Institutions can apply for grants of up to $40,000 per year for projects lasting up to five years, with a submission deadline of January 30, 2025. Interested applicants should ensure compliance with eligibility criteria and submit detailed proposals that include innovative educational plans and collaborations with relevant disciplines; for further inquiries, contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "National Centers for Biomedical Imaging and Bioengineering (NCBIB)" aimed at supporting the development and dissemination of new biomedical technologies. This initiative encourages applications from a diverse range of eligible entities, including higher education institutions and nonprofit organizations, to conduct technology research and development projects, collaborative projects, and service projects that address biomedical challenges. The program is designed to foster innovative research and enhance clinical applications, with funding typically ranging from $600,000 to $750,000 per project, and awards may last up to five years, with a total funding cap of fifteen years for any Center. Interested applicants should note that the application process opens on September 25, 2023, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov. For more details, please refer to the full announcement available at https://grants.nih.gov/grants/guide/pa-files/PAR-23-235.html.
    Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Bioengineering Research Grants (BRG), aimed at fostering multidisciplinary collaborations to address significant biomedical challenges. This funding opportunity encourages innovative research that integrates life and physical sciences to develop tools, methods, and technologies that can enhance healthcare delivery and medical practices. Eligible applicants include a diverse range of institutions, such as historically black colleges, tribal colleges, and community-based organizations, with projects allowed to span up to five years under the R01 grant mechanism. Interested parties should submit their applications electronically by September 7, 2025, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov.
    Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)" aimed at fostering collaborative research between academic institutions and industrial partners to accelerate the development of innovative bioengineering tools addressing critical biomedical challenges. This initiative seeks multidisciplinary teams that integrate engineering principles to create robust solutions capable of enhancing life sciences understanding and medical practices within a 5-10 year timeframe. The program emphasizes the importance of partnerships in overcoming development barriers and facilitating technology validation and commercialization, ultimately aiming to improve patient health outcomes. Interested applicants can find more details and submit inquiries via the NIH OER Webmaster at OERWebmaster03@od.nih.gov, with applications due by January 7, 2025.
    Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional)" aimed at developing medical technologies that address health disparities among underserved populations in the U.S. This initiative encourages grant applications focused on creating effective, affordable, culturally acceptable, and accessible medical solutions, including devices, imaging systems, and telehealth innovations, while emphasizing the importance of formal collaborations with healthcare organizations serving these populations. The NIH plans to allocate approximately $2.4 million for this initiative, with an award ceiling of $500,000 per project, and expects to fund 3-4 awards over a project duration of up to four years. Interested applicants must submit their proposals by May 2, 2025, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Exploratory/Developmental Bioengineering Research Grants (EBRG) under the R21 mechanism, aimed at fostering innovative engineering solutions to advance biomedical research. This funding opportunity encourages applications from a diverse range of organizations, including higher education institutions and nonprofits, to support exploratory projects that demonstrate feasibility and potential utility in addressing critical challenges in biomedical research and clinical care delivery, without involving clinical trials. The initiative emphasizes collaboration between quantitative and physical scientists and biomedical researchers, aiming to facilitate early-stage developments that can lead to significant advancements in medical technologies and methods. The funding ceiling is set at $275,000 over two years, with applications due by January 7, 2025. For further inquiries, interested parties can contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov, and additional details can be found at the provided link: http://grants.nih.gov/grants/guide/pa-files/PAR-22-090.html.
    Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the Exploratory/Developmental Bioengineering Research Grants (EBRG) under the R21 funding mechanism, aimed at fostering innovative projects that address significant biomedical challenges. This funding opportunity encourages applications that explore new capabilities or improvements in biomedical research, clinical care delivery, and accessibility, with a focus on groundbreaking engineering research and collaboration across diverse scientific disciplines. Eligible applicants include higher education institutions, nonprofits, and small businesses, with a budget cap of $275,000 over two years, and applications are due by January 7, 2025. For further inquiries, interested parties can contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov or visit the additional information link at http://grants.nih.gov/grants/guide/pa-files/PAR-22-091.html.
    Focused Technology Research and Development (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Focused Technology Research and Development (R01 Clinical Trial Not Allowed) grant, aimed at supporting projects that develop innovative technologies to enhance biomedical research capabilities. Eligible applicants include a diverse range of institutions such as Historically Black Colleges and Universities, Tribal Colleges, and various community-based organizations, with a focus on projects that have demonstrated proof of principle but still face significant technical challenges. This initiative emphasizes the development of laboratory instruments, algorithms, and biological systems, while applications targeting specific biomedical questions will not be funded. Interested parties should note that the application deadline is May 7, 2025, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries. More details can be found at the provided link: http://grants.nih.gov/grants/guide/pa-files/PAR-22-127.html.
    Leading Equity and Diversity in the Medical Scientist Training Program (LEAD MSTP)(T32)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Leading Equity and Diversity in the Medical Scientist Training Program (LEAD MSTP) (T32)," aimed at enhancing diversity within the biomedical research workforce. This initiative seeks to support dual-degree clinician-scientist training at institutions that have historically been underrepresented in NIH-funded programs, specifically targeting Historically Black Colleges and Universities (HBCUs), Tribal Colleges and Universities (TCUs), and institutions in states eligible for the Institutional Development Award (IDeA) program. The program is designed to develop a skilled workforce capable of addressing health disparities and fulfilling the nation’s biomedical research needs, with funding available for stipends, tuition, and training-related expenses for up to five years. Interested institutions must submit their applications by January 27, 2025, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov.